| Circulating markers of liver fibrosis progression P Jarčuška, M Janičko, E Veselíny, P Jarčuška, Ľ Skladaný Clinica Chimica Acta 411 (15-16), 1009-1017, 2010 | 117 | 2010 |
| Identification of optimal therapeutic window for steroid use in severe alcohol-associated hepatitis: a worldwide study JP Arab, LA Díaz, N Baeza, F Idalsoaga, E Fuentes-López, J Arnold, ... Journal of hepatology 75 (5), 1026-1033, 2021 | 105 | 2021 |
| A global research priority agenda to advance public health responses to fatty liver disease JV Lazarus, HE Mark, AM Allen, JP Arab, P Carrieri, M Noureddin, ... Journal of hepatology 79 (3), 618-634, 2023 | 70 | 2023 |
| Anti-inflammatory adipokines: chemerin, vaspin, omentin concentrations and SARS-CoV-2 outcomes M Kukla, T Menżyk, M Dembiński, M Winiarski, A Garlicki, ... Scientific reports 11 (1), 21514, 2021 | 33 | 2021 |
| Glucose metabolism changes in patients with chronic hepatitis C treated with direct acting antivirals S Drazilova, M Janicko, L Skladany, P Kristian, M Oltman, M Szantova, ... Canadian Journal of Gastroenterology and Hepatology 2018 (1), 6095097, 2018 | 32 | 2018 |
| Liver injury associated with the use of selective androgen receptor modulators and post-cycle therapy: Two case reports and literature review T Koller, P Vrbova, I Meciarova, P Molcan, M Smitka, SA Selcanova, ... World journal of clinical cases 9 (16), 4062, 2021 | 30 | 2021 |
| Frailty in nonalcoholic fatty liver cirrhosis: a comparison with alcoholic cirrhosis, risk patterns, and impact on prognosis L Skladany, P Molcan, J Vnencakova, P Vrbova, M Kukla, L Laffers, ... Canadian Journal of Gastroenterology and Hepatology 2021 (1), 5576531, 2021 | 29 | 2021 |
| Prognostic usefulness of serum myostatin in advanced chronic liver disease: its relation to gender and correlation with inflammatory status. L Skladany, T Koller, P Molcan, J Vnencakova, M Zilincan, D Jancekova, ... Journal of Physiology & Pharmacology 70 (3), 2019 | 25 | 2019 |
| Effects of polyphenol compounds melanin on NAFLD/NASH prevention N Belemets, N Kobyliak, O Virchenko, T Falalyeyeva, T Olena, P Bodnar, ... Biomedicine & Pharmacotherapy 88, 267-276, 2017 | 25 | 2017 |
| Challenging management of severe chronic disorders in acute pandemic situation: Chronic liver disease under COVID-19 pandemic as the proof-of-principle model to orchestrate the … L Skladany, T Koller, S Adamcova Selcanova, J Vnencakova, ... EPMA Journal 12, 1-14, 2021 | 24 | 2021 |
| Applicability and prognostic value of frailty assessment tools among hospitalized patients with advanced chronic liver disease L Skladany, Z Drotarova, J Vnencakova, D Jancekova, P Molcan, T Koller Croatian Medical Journal 62 (1), 8-16, 2021 | 23 | 2021 |
| Irisin in liver cirrhosis M Kukla, L Skladany, T Menżyk, A Derra, D Stygar, M Skonieczna, D Hudy, ... Journal of clinical medicine 9 (10), 3158, 2020 | 23 | 2020 |
| Alcohol use relapse following liver transplantation for alcoholic liver disease L Skladany, SA Selcanova, T Koller Annals of transplantation 24, 359, 2019 | 21 | 2019 |
| Adherence to oral nutritional supplements after being discharged from the hospital is low but improves outcome in patients with advanced chronic liver disease L Skladany, J Vnencakova, L Laffers, B Skvarkova, E Hrubá, P Molcan, ... Patient preference and adherence, 2559-2572, 2021 | 20 | 2021 |
| Nanocrystalline cerium dioxide efficacy for prophylaxis of erosive and ulcerative lesions in the gastric mucosa of rats induced by stress D Golyshkin, N Kobyliak, O Virchenko, T Falalyeyeva, T Beregova, ... Biomedicine & Pharmacotherapy 84, 1383-1392, 2016 | 20 | 2016 |
| Fetuin-A deficiency but not pentraxin 3, FGF-21, or irisin, predisposes to more serious COVID-19 course M Kukla, T Menżyk, M Dembiński, M Winiarski, A Garlicki, ... Biomolecules 11 (10), 1422, 2021 | 19 | 2021 |
| MELD 3.0 adequately predicts mortality and renal replacement therapy requirements in patients with alcohol-associated hepatitis LA Díaz, E Fuentes-López, G Ayares, F Idalsoaga, J Arnold, MA Valverde, ... JHEP Reports 5 (8), 100727, 2023 | 15 | 2023 |
| Chemerin as a potential marker of resolution of inflammation in COVID-19 infection J Sulicka-Grodzicka, A Surdacki, M Surmiak, M Sanak, B Wizner, W Sydor, ... Biomedicines 10 (10), 2462, 2022 | 15 | 2022 |
| Relationship between alcohol consumption and adverse childhood experiences in college students–A cross-sectional study K Šulejová, D Líška, E Liptáková, M Szántová, M Patarák, T Koller, ... Frontiers in psychology 13, 1004651, 2022 | 10 | 2022 |
| Alcoholic liver disease-related hepatocellular carcinoma: characteristics and comparison to general Slovak hepatocellular cancer population D Šafčák, S Dražilová, J Gazda, I Andrašina, S Adamcová-Selčanová, ... Current Oncology 30 (3), 3557-3570, 2023 | 8 | 2023 |
Peter JarcuskaAssociate professor, 1st Dept of Internal Medicine, UPJS LF Kosice, SlovakiaOverená e-mailová adresa na: upjs.sk
